Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Krebsbach

Podiatrist Franklin, WI Doctor of Podiatric Medicine

NPI 1598704793 CMS profile 298452

7400 W Rawson Ave, Suite 231, Franklin, WI 53132

Open in the dashboard

General payments

$5,676

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Krebsbach of Franklin, WI is reported in the CMS Open Payments database as having received $5,676 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,148 13
2024 General $490 8
2023 General $1,613 10
2022 General $810 9
2021 General $900 10
2020 General $484 10
2019 General $232 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Krebsbach
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to John Krebsbach were reported at $1,148. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year John Krebsbach Podiatrist median Middle half National median
2019 $232 $196 $72–$601 $163
2020 $484 $118 $38–$335 $114
2021 $900 $169 $57–$573 $132
2022 $810 $220 $74–$782 $149
2023 $1,613 $208 $71–$635 $160
2024 $490 $237 $87–$681 $164
2025 $1,148 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,748 22 payments
  2. Integra LifeSciences Corporation $905 15 payments
  3. RELJA Innovations LLC $900 1 payment
  4. Aroa Biosurgery Incorporated $287 4 payments
  5. Sanara MedTech Inc. $251 2 payments
  6. Acera Surgical, Inc. $239 4 payments
  7. Kerecis Limited $180 2 payments
  8. Orthofix Medical, Inc. $175 1 payment
  9. Treace Medical Concepts, Inc. $150 1 payment
  10. Nevro Corp. $145 1 payment
  11. Other $696 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,776 62 payments
  2. Consulting Fee $900 1 payment
Products named General payments · program years 2019–2025
  1. RELJA Reduction Clamp $900 1 payment
  2. INTEGRA DERMAL REGENERATION TEMPLATE $712 10 payments
  3. PRIMATRIX $712 10 payments
  4. Integra Recon-Skin And Wound $417 7 payments
  5. Integra Recon-Skin And Wound $417 7 payments
  6. Integra Recon-Skin And Wound $417 7 payments
  7. CITREFIX $367 3 payments
  8. ORTHOLOC 2 LAPIFUSE $362 4 payments
  9. INTEGRA WOUND MATRIX (THIN) $294 3 payments
  10. INTEGRA MESHED BILAYER WOUND MATRIX $294 3 payments
  11. Other $5,496 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

269

Median for Podiatry: 160

Drug cost

$4,266

Median for Podiatry: $2,368

Branded share of claims

8.2%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ammonium Lactate Generic 34 $909
Ketoconazole Generic 36 $885
Terbinafine Hcl Generic 74 $811
Doxycycline Monohydrate Generic 21 $432
Allopurinol Generic 31 $431
Diclofenac Sodium Generic 17 $339
Oxycodone Hcl Generic 23 $215
Ciprofloxacin Hcl Generic 11 $126
Nystop Nystatin Brand 22 $119

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$61,836

Medicare's payments for the services billed

Medicare patients

411

Average age 76

Services billed

1,733

236 women, 175 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 52%
Diabetes 42%
Ischemic heart disease 31%
Chronic kidney disease 29%
Depression 24%
Atrial fibrillation 21%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record